Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health

被引:5
|
作者
Zhu, Ruixin [1 ]
Wang, Ran [1 ]
He, Jingjing [1 ]
Wang, Langrun [1 ]
Chen, Huiyu [1 ]
Niu, Xiaokang [1 ]
Sun, You [2 ]
Guan, Yiran [1 ]
Gong, Yifan [1 ]
Zhang, Liwei [1 ]
An, Peng [1 ]
Li, Keji [3 ]
Ren, Fazheng [1 ]
Xu, Weili [4 ]
Guo, Jie [1 ,4 ]
机构
[1] China Agr Univ, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual, 10 Tianxiu Rd, Beijing, Peoples R China
[2] Tianjin Univ Sci & Technol, Coll Food Sci & Engn, Tianjin, Peoples R China
[3] Peking Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing, Peoples R China
[4] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Solna, Sweden
基金
中国博士后科学基金;
关键词
US ADULTS; NHANES;
D O I
10.1001/jamanetworkopen.2024.45309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Cardiovascular-kidney-metabolic (CKM) syndrome-a novel, multistage, multisystem disorder as defined by the American Heart Association-is highly prevalent in the US. However, the prevalence of CKM stages by social determinants of health (SDOH) remains unclear. Objective To investigate whether the prevalence of CKM stages varies by SDOH in US adults. Design, Setting, and Participants This cross-sectional study used data from the National Health and Nutrition Examination Survey (1999-2018) and included a nationally representative sample of adults aged 30 to 79 years through complex, multistage probability sampling. Data were analyzed from April 1 to June 15, 2024. Exposures The exposures included 5 CKM stages (ie, stages 0-4) reflecting progressive pathophysiology, with advanced (stages 3 or 4) and nonadvanced (stages 0, 1, or 2) disease. CKM stages were defined based on risk factors for metabolic syndrome, cardiovascular disease, and chronic kidney disease. Main Outcome and Measures The main outcome was the age-standardized prevalence of CKM stages and advanced CKM stages across SDOH, including education, marital status, family income, food security, health insurance, employment, home ownership, and health care access. Results Among 29 722 participants (weighted mean [SE] age, 50.8 [0.1] years; weighted 50.7% male), the age-standardized prevalence of CKM stages 0 to 4 was 13.6% (95% CI, 13.0%-14.3%), 29.9% (95% CI, 29.1%-30.7%), 43.7% (95% CI, 42.9%-44.5%), 4.7% (95% CI, 4.4%-5.0%), and 8.1% (95% CI, 7.6%-8.5%), respectively. Significant differences were observed in the prevalence of CKM stages across all unfavorable SDOH of interest compared with their favorable counterparts, with unemployment (18.8% [95% CI, 17.7%-20.1%] vs 11.4% [95% CI, 11.0%-11.9%]), low family income (16.1% [95% CI, 15.4%-16.8%] vs 10.1% [95% CI, 9.5%-10.7%]), and food insecurity (18.3% [95% CI, 17.1%-19.6%] vs 11.7% [95% CI, 11.2%-12.2%]) associated with an increased likelihood of advanced CKM stages. Participants with 2 or more unfavorable SDOH were more likely to have advanced CKM stages (age-standardized prevalence, 15.8% [95% CI, 15.2%-16.5%] vs 10.5% [95% CI, 9.9%-11.1%] with <2 unfavorable SDOH). Living in a rented home (15.9% [95% CI, 14.7%-17.0%] vs 9.3% [95% CI, 8.7%-9.9%] owning the home) or not living with a partner (13.2% [95% CI, 12.3%-14.3%] vs 9.2% [95% CI, 8.5%-9.8%] living with a partner) increased the likelihood of advanced CKM stages in female but not male participants. Conclusions and Relevance In this cross-sectional study, disparities in the prevalence of CKM stages by SDOH, particularly family income, food security, and employment, with notable sex differences, were observed in US adults. These findings highlight the need to address inequities in CKM syndrome through targeted interventions.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Defining high risk in the cardiovascular-kidney-metabolic syndrome and associated cardiovascular disease outcomes
    Shah, N.
    Huang, X.
    Yang, S.
    Allen, N. B.
    Chaker, L.
    Bos, D.
    Ikram, M. K.
    Ndumele, C. E.
    Lloyd-Jones, D. M.
    Petito, L. C.
    Kavousi, M.
    Khan, S. S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [32] Amino Acids during Pregnancy and Offspring Cardiovascular-Kidney-Metabolic Health
    Tain, You-Lin
    Hsu, Chien-Ning
    NUTRIENTS, 2024, 16 (09)
  • [33] A NOVEL CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME MOUSE MODEL WITH INDUCIBLE HFREF AND ATHEROSCLEROSIS
    Inia, Jose
    Van Koppen, Arianne
    De Ruiter, Christa
    Attema, Joline
    Gonzalez-Villalobos, Romer
    Nawrocki, Andrea
    Hinke, Simon
    Nguyen, Tri
    Dendooven, Amelie
    Bajema, Ingeborg
    Van Goor, Harry
    Tseng, Karen
    Hsu, Wei-Chan
    Menke, Aswin
    Smits, Anke
    Breyer, Matthew
    Jukema, Wouter
    Stoop, Reinout
    Princen, Hans
    Pieterman, Elsbet
    ATHEROSCLEROSIS, 2024, 395
  • [34] Cardiovascular-Kidney-Metabolic Syndrome Among Healthcare Workers in Chinese Tertiary Hospital
    Zhang, Qingqing
    Zheng, Jing
    Wang, Guoyu
    Jiang, Suyun
    Gao, Peng
    Sun, Si
    Ding, Xiangwei
    Wu, Yucheng
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2024, 17 : 2647 - 2657
  • [35] Abdominal obesity and frailty progression in population across different Cardiovascular-Kidney-Metabolic syndrome stages: a nationwide longitudinal study
    Zhang, Chong
    Hao, Cuijun
    Liang, Weiru
    Hu, Kun
    Guo, Tingting
    Chen, Yi
    Ning, Meng
    Liu, Yingwu
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01):
  • [36] Cardiovascular-Kidney-Metabolic Health Syndrome: What Does the American Heart Association Framework Mean for Nephrology?
    Bansal, Nisha
    Weiner, Daniel
    Sarnak, Mark
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (05): : 649 - 652
  • [37] Cardiovascular-kidney-metabolic Syndrome Entangled: "In Rhythm with Time, from Days to Years"
    Mizuno, Atsushi
    JMA JOURNAL, 2025, 8 (01): : 286 - 287
  • [38] Cardiovascular-kidney-metabolic Syndrome Entangled: "In Rhythm with Time, from Days to Years"
    Mizuno, Atsushi
    JMA JOURNAL, 2024,
  • [39] Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
    Ndumele, Chiadi E.
    Rangaswami, Janani
    Chow, Sheryl L.
    Neeland, Ian J.
    Tuttle, Katherine R.
    Khan, Sadiya S.
    Coresh, Josef
    Mathew, Roy O.
    Baker-Smith, Carissa M.
    Carnethon, Mercedes R.
    Despres, Jean-Pierre
    Ho, Jennifer E.
    Joseph, Joshua J.
    Kernan, Walter N.
    Khera, Amit
    Kosiborod, Mikhail N.
    Lekavich, Carolyn L.
    Lewis, Eldrin F.
    Lo, Kevin B.
    Ozkan, Bige
    Palaniappan, Latha P.
    Patel, Sonali S.
    Pencina, Michael J.
    Powell-Wiley, Tiffany M.
    Sperling, Laurence S.
    Virani, Salim S.
    Wright, Jackson T.
    Singh, Radhika Rajgopal
    Elkind, Mitchell S. V.
    Amer Heart Assoc
    CIRCULATION, 2023, 148 (20) : 1606 - 1635
  • [40] Defining the role of NOX5 as a biomarker in the Cardiovascular-Kidney-Metabolic syndrome
    Pinzon-Cortes, J.
    Sourris, K. C.
    Block, T. J.
    Kincses, A.
    Jha, J. C.
    Cooper, M. E.
    Shaw, J.
    Jandeleit-Dahm, K.
    DIABETOLOGIA, 2024, 67 : S486 - S486